Sanna Hulkki
Royal Marsden NHS Foundation Trust(GB)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, Acute Myeloid Leukemia Research, Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma(2012)245 cited
- → Ultra-Sensitive Mutation Detection and Genome-Wide DNA Copy Number Reconstruction by Error-Corrected Circulating Tumor DNA Sequencing(2018)56 cited
- → The genomic landscape of oesophagogastric junctional adenocarcinoma(2013)46 cited
- → Tyrosine kinase inhibitor insensitivity of non‐cycling CD34+ human acute myeloid leukaemia cells with FMS‐like tyrosine kinase 3 mutations(2011)7 cited
- → Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme(2018)4 cited
- → Ultra-sensitive mutation detection and genome-wide DNA copy number reconstruction by error corrected circulating tumour DNA sequencing(2017)4 cited
- → Single-Cell Genetic Analysis Reveals The Genetic Composition Of Founder Clones, Phylogenetic Patterns Of Branching and Parallel Evolution, and Clonal Fluctuations Following Patient Treatment In Multiple Myeloma(2013)2 cited
- → Non-Cycling Cells From Acute Myeloid Leukemia Patients Harbor the FLT3-ITD Mutation and Are Insensitive to TKI258, a Potent FLT3-Directed Inhibitor, in Vitro.(2009)2 cited
- Non-cycling cells from acute myeloid leukaemia patients harbor the FLT3-ITD (FMS-like tyrosine kinase 3-internal tandem duplication) mutation and exhibit in vitro insensitivity to TKI258, a potent FLT3-directed inhibitor(2010)